Company Filing History:
Years Active: 2014-2017
Title: Roberta Weiss: Innovator in Anti-TNFα Antibody Treatments
Introduction
Roberta Weiss is a prominent inventor based in Wynnewood, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods for administering anti-TNFα antibodies. With a total of seven patents to her name, her work has the potential to impact the treatment of various disorders.
Latest Patents
Her latest patents focus on methods of treating disorders where TNFα activity is detrimental. These methods involve biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα). The antibodies may be administered with or without methotrexate. They exhibit high affinity for hTNFα and have a slow off rate for hTNFα dissociation, effectively neutralizing hTNFα activity both in vitro and in vivo. The invention also encompasses kits containing pharmaceutical compositions and instructions for dosing, as well as preloaded syringes.
Career Highlights
Roberta Weiss has established herself as a key figure in the biotechnology sector. Her innovative approaches to antibody treatments have garnered attention and respect within the scientific community.
Collaborations
She has collaborated with notable colleagues, including Steven Alan Fischkoff and Joachim Kempeni, further enhancing her contributions to the field.
Conclusion
Roberta Weiss's work in developing anti-TNFα antibody treatments exemplifies her dedication to advancing medical science. Her patents and collaborations reflect her significant impact on biotechnology and patient care.